Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32594120.
- Also identified by DOI 10.1093/cid/ciaa883 and PMC identifier 7337726.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of a man with COVID-19 who developed acute hepatotoxicity related to remdesivir with probable interaction of P-glycoprotein (P-gp) inhibitors. Until further details on this interaction become available, we recommend physicians to be cautious with the prescription of P-gp inhibitors in patients receiving remdesivir therapy.
Medical subject headings
- Chemical and Drug Induced Liver Injury
- COVID-19 Drug Treatment